Showing 331-340 of 936 results for "".
Bruton Tyrosine Kinase Inhibition in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/bruton-tyrosine-kinase-inhibition-in-multiple-sclerosis/31872/The missing link for treatment optimization?Radiologic Differential Diagnosis of Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/radiologic-differential-diagnosis-of-multiple-sclerosis/54601/This article provides an overview of the radiographic features that are shared and those that are distinct among multiple sclerosis, aquaporin-4 antibody–positive neuromyelitis optica spectrum disorder, and myelin oligodendrocyte protein antibody–associated disease.Neuro-Ophthalmology Notions: The Optic Nerve as Topographic Marker in the 2024 McDonald Diagnostic Criteria for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/neuro-ophthalmology-notions-the-optic-nerve-as-topographic-marker-in-the-2024-mcdonald-diagnostic-criteria-for-multiple-sclerosis/35447/Neuro-ophthalmic evaluations assist in early diagnosis of multiple sclerosis.MS Minute: Menopause and Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minutebrmenopause-and-multiple-sclerosis/32119/Multiple sclerosis and menopause have overlapping symptoms, complicating evaluation of disease progression and care of this population.The 401K Today: What Every Neurologist Practice Must Know
https://practicalneurology.com/columns/practice-management/the-401k-today-what-every-neurologist-practice-must-know/30668/How to ensure you're in compliance with the DOL's revised ERISA rules governing 401K plans.Malpractice Prevention Strategies
https://practicalneurology.com/columns/practice-management/malpractice-prevention-strategies/30234/The inherent risk of medicine mandates both risk management and asset protection.PFO in Cryptogenic Stroke Patients
https://practicalneurology.com/diseases-diagnoses/stroke/pfo-in-cryptogenic--stroke-patients/30817/The lead investigator from the REDUCE trial discusses his perspective on how these patients should be approached.Spinal Cord Infarct: Clinical & Imaging Pearls
https://practicalneurology.com/diseases-diagnoses/imaging-testing/spinal-cord-infarct-clinical--imaging-pearls/30394/Posterior Reversible Encephalopathy Syndrome (PRES): A Case Report and Review of the Literature
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/posterior-reversible-encephalopathy-syndrome-pres-a-case-report-and-review-of-the-literature/30477/News
https://practicalneurology.com/columns/practice-management/news/30576/